已发表论文

miR-196b 的高表达预测卵巢癌患者的预后不良

 

Authors Li Y, Li J, Liu Z, Zhang Y

Received 27 March 2020

Accepted for publication 20 August 2020

Published 1 October 2020 Volume 2020:13 Pages 9797—9806

DOI https://doi.org/10.2147/OTT.S254942

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr William Cho

Background/Aims: To analyze the clinical significance of miR-196b expression in ovarian cancer and predict the function and possible mechanism of miR-196b.
Methods: Both Kaplan–Meier (K-M) and Cox proportional hazards regression model were used to analyze the prognostic factors of patients with ovarian cancer. MiR196-b was modulated in ovarian cancer cells, and the cell viability, cell cycle, and cell cycle-related gene expression were analyzed. The target genes of miR-196b were then predicted and checked the relationship between the target genes.
Results: MiR-196b was an independent risk factor, while high expression of miR-196b was associated with poor prognosis of ovarian cancer. MiR-196b overexpression increased cancer cell proliferation. Cdkn1b, as one of the targets of miR-196b, was related to cell viability and mitosis.
Conclusion: High expression of miR-196b was significantly associated with poor prognosis of the patients with ovarian cancer. MiR-196b could increase the cell proliferation of ovarian cancer by modulating Cdkn1b expression.
Keywords: microRNAs, MiR-196b, ovarian cancer, Cdkn1b, proliferation




Figure 1 The overall survival of patient with ovarian cancer cut-off by miR-196b expression.